RGC Stock Analysis: Buy, Sell, or Hold?
RGC - Regencell Bioscience Holdings Limited Ordinary Shares
$6.18
0.24 (4.04%)
▲
5d:
+8.04%
30d:
-23.04%
90d:
-78.85%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Oct 28, 2026
Get Alerted When RGC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: RGC shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: RGC shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: RGC is currently trading at $6.18, which is considered fair relative to its 30-day fair value range of $5.24 to $6.63.
Technical Outlook: Technically, RGC is in a strong downtrend. The price is approaching resistance at $6.35. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: RGC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RGC is in a strong downtrend. The price is approaching resistance at $6.35. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: RGC has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$5.24 -
$6.63
Company Quality Score
45/100
(HOLD)
Options IV Signal
56th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
86.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 56th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.0%)
Trading Range Analysis
30-Day Trading Range
$5.24 -
$6.63
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$1.83
(29.6%)
Support & Resistance Levels
Support Level
$4.92
Resistance Level
$6.35
Current Trend
Strong Downtrend
Technical data as of
Jul 31, 2026
Fundamental Context
Share & Embed Analysis
Last updated: August 03, 2026 3:35 AM ET
Data refreshes hourly during market hours. Next update: 4:35 AM
Data refreshes hourly during market hours. Next update: 4:35 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RGC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$211 | 60 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$112 | 52 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$663 | 48 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$113 | 45 HOLD |
|
AVDL
Avadel Pharmaceuticals P… |
STRONG BUY
8 analysts |
$21 | 62 BUY |
